​

Funding Round

Series A - Mironid

Series A - Mironid

Investment Firm

Overview

Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.

Announced Date

Sep 13, 2023

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

Roche Venture Fund

Roche Venture Fund

Roche Venture Fund is a early_stage_venture and late_stage_venture firm.

Participant Investors

7

Investor Name
Participant InvestorEuropean Investment Fund
Participant InvestorSofinnova Partners
Participant InvestorRoche Venture Fund
Participant InvestorBioGeneration Ventures
Participant InvestorScottish Enterprise

Round Details and Background

Mironid raised $38343127 on 2023-09-13 in Series A

Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 13, 2023
Series A - Mironid
7-38.3M
Jun 20, 2016
Series A - Mironid
2-6.3M

Recent Activity

There is no recent news or activity for this profile.